ELTP - Elite Pharmaceuticals Inc. (ELTP) CEO Nasrat Hakim on Q2 2022 Results - Earnings Call Transcript

Elite Pharmaceuticals, Inc. (ELTP) Q2 2022 Earnings Conference Call November 16, 2021, 11:30 AM ET Company Participants Nasrat Hakim - President and CEO Marc Bregman - CFO Conference Call Participants Presentation Operator Good morning, ladies and gentlemen and welcome to the Elite Pharmaceuticals Conference Call. At this time, all lines have been placed on a listen-only mode. Before management begins speaking, the Company has the following statements. Elite would like to remind their listeners that remarks made during this call may contain forward-looking statements that involve risks and uncertainties and are subject to changes at any time, including, but not limited to, statements about Elite's expectations regarding future operating results. Forward-looking statements are made pursuant to the safe harbor provisions of the Federal Securities Laws and represent management's current expectations. Actual results may differ materially. Elite disclaims any obligation to update or revise its forward-looking statements, except as required by

For further details see:

Elite Pharmaceuticals, Inc. (ELTP) CEO Nasrat Hakim on Q2 2022 Results - Earnings Call Transcript